ReviewInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2023

Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions.

Thomas J Herzog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.